SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-021060
Filing Date
2018-08-09
Accepted
2018-08-09 16:15:39
Documents
9
Period of Report
2018-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20180808.htm 8-K 36539
2 EX-1.1 sbph-ex11_211.htm EX-1.1 343114
3 EX-5.1 sbph-ex51_9.htm EX-5.1 13950
4 EX-99.1 sbph-ex991_8.htm EX-99.1 11063
5 EX-99.2 sbph-ex992_144.htm EX-99.2 11115
6 EX-99.3 sbph-ex993_281.htm EX-99.3 18137
7 GRAPHIC gmlrmfxosta1000001.jpg GRAPHIC 5029
8 GRAPHIC gamgjosh4qyv000001.jpg GRAPHIC 5029
9 GRAPHIC g4o5zug1th1u000001.jpg GRAPHIC 3110
  Complete submission text file 0001564590-18-021060.txt   453705
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 181005214
SIC: 2834 Pharmaceutical Preparations